PRICE T ROWE ASSOCIATES INC /MD/ - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$16,556,000
+115.4%
320,461
+3.3%
0.00%
+200.0%
Q2 2022$7,685,000
-16.2%
310,129
-15.2%
0.00%0.0%
Q1 2022$9,166,000
-31.5%
365,634
-0.5%
0.00%0.0%
Q4 2021$13,378,000
+107.7%
367,423
-2.4%
0.00%0.0%
Q3 2021$6,440,000
+8.1%
376,622
-15.3%
0.00%0.0%
Q2 2021$5,957,000
-73.4%
444,898
+2.0%
0.00%
-50.0%
Q1 2021$22,355,000
-10.4%
436,276
+8.2%
0.00%
-33.3%
Q4 2020$24,962,000
+62.0%
403,128
+43.4%
0.00%
+50.0%
Q3 2020$15,408,000
-57.7%
281,162
-55.6%
0.00%
-60.0%
Q2 2020$36,420,000
+439.6%
632,957
+276.8%
0.01%
+400.0%
Q1 2020$6,749,000
+86.3%
167,964
+83.4%
0.00%
Q4 2019$3,623,000
-42.1%
91,600
-80.1%
0.00%
-100.0%
Q1 2018$6,258,000
+74.0%
460,141
-28.9%
0.00%0.0%
Q3 2013$3,596,000
-81.0%
646,800
-51.8%
0.00%
-66.7%
Q2 2013$18,974,0001,341,8000.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 296,327$7,429,0002.90%
Integral Health Asset Management, LLC 400,000$10,028,0002.61%
Cormorant Asset Management, LP 865,000$21,686,0001.66%
HealthCor Management, L.P. 956,740$23,985,0001.60%
Sofinnova Investments, Inc. 573,684$14,382,0001.09%
Lisanti Capital Growth, LLC 321,569$8,062,0000.91%
Cahill Wealth Management, LLC 44,913$1,125,0000.84%
Perceptive Advisors 1,655,079$41,493,0000.83%
RA Capital Management 1,155,964$28,980,0000.63%
Avidity Partners Management LP 1,175,000$29,457,0000.61%
View complete list of CHEMOCENTRYX INC shareholders